These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 3806593)

  • 21. New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.
    Talebian A; Green D; Hammer CF; McPherson E; Schein PS
    J Pharm Sci; 1990 Dec; 79(12):1105-8. PubMed ID: 2127804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Schlein A; Huftalen JB
    Cancer Res; 1984 Dec; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New 2-substituted indoloquinone mitomycin analogues.
    Iyengar BS; Remers WA; Catino JJ
    J Med Chem; 1989 Aug; 32(8):1866-72. PubMed ID: 2754710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
    Kono M; Saitoh Y; Kasai M; Sato A; Shirahata K; Morimoto M; Ashizawa T
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1128-30. PubMed ID: 2766417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of tropolone derivatives. 3.
    Yamato M; Hashigaki K; Kokubu N; Tashiro T; Tsuruo T
    J Med Chem; 1986 Jul; 29(7):1202-5. PubMed ID: 3806570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
    Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
    J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
    Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The derivation of 1a-demethylmitomycin G from mitomycin C.
    Kono M; Kasai M; Shirahata K; Morimoto M
    J Antibiot (Tokyo); 1990 Apr; 43(4):383-90. PubMed ID: 2112532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new antitumor agent: methyl sulfonium perchlorate of echinomycin.
    Park YS; Kim YH; Kim SK; Choi SJ
    Bioorg Med Chem Lett; 1998 Apr; 8(7):731-4. PubMed ID: 9871531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New cyanomorpholinyl byproduct of doxorubicin reductive alkylation.
    Acton EM; Tong GL; Taylor DL; Filppi JA; Wolgemuth RL
    J Med Chem; 1986 Jul; 29(7):1225-30. PubMed ID: 3806572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of acyclic neplanocin analogues.
    Hua M; Korkowski PM; Vince R
    J Med Chem; 1987 Jan; 30(1):198-200. PubMed ID: 3027333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformations of complexes between mitomycins and decanucleotides. 3. Sequence specificity, binding at C-10, and mitomycin analogues.
    Remers WA; Rao SN; Wunz TP; Kollman PA
    J Med Chem; 1988 Aug; 31(8):1612-20. PubMed ID: 3397999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.